Obesity drugs aren't always forever. What happens when you quit?

Nature. 2024 Apr;628(8008):488-490. doi: 10.1038/d41586-024-01091-8.
No abstract available

Keywords: Drug discovery; Metabolism; Obesity.

Publication types

  • News

MeSH terms

  • Glucagon-Like Peptide-1 Receptor Agonists* / administration & dosage
  • Glucagon-Like Peptide-1 Receptor Agonists* / therapeutic use
  • Glucagon-Like Peptides* / administration & dosage
  • Glucagon-Like Peptides* / therapeutic use
  • Humans
  • Obesity* / drug therapy
  • Research Personnel
  • Time Factors

Substances

  • Glucagon-Like Peptide-1 Receptor Agonists
  • Glucagon-Like Peptides
  • semaglutide